Sarcoidosis is an inflammatory disease which is characterized by chronic, systemic noncaseating granuloma formation. This disease generally affects the respiratory system. Bone lesions in sarcoidosis are developed in the cases with 3-13 percentage that generally asymptomatic. In this study we presented a patient of sarcoidosis that had been pulmoner symptoms a long time, and then diagnosed with excisional biopsy from her rib bone.
___
Moore SL, Teirstein AE. Musculoskeletal sarcoidosis: spectrum of appearances at MR imaging. Radiographics. 2003;23(6):1389-99
Miller BJ. Sarcoidosis. Am J Orthop. 2003;32(8):371-2.
Visser H, Vos K, Zanelli E, Verduyn W, Schreuder GM, Speyer I, Breedveld FC, Hazes JM. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors. Ann Rheum Dis. 2002;61(6):499- 504.
Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, Terrin ML, Weinberger SE, Moller DR, McLennan G, Hunninghake G, DePalo L, Baughman RP, Iannuzzi MC, Judson MA, Knatterud GL, Thompson BW, Teirstein AS, Yeager H Jr, Johns CJ, Rabin DL, Rybicki BA, Cherniack R; ACCESS Research Group. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170(12):1324-30.
Torralba KD, Quismorio FP, Jr. Sarcoidosis and the rheumatolo gist. Curr Opin Rheumatol. 2009;21(1):62-70.
Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336(17):1224-34.
Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736-55.
Anakwenze OA, Kancherla V, Hatch M, Brooks JS, Ogilvie CM. Pri- mary musculoskeletal sarcoidosis. Orthopedics. 2010;33(5).
Matsui K, Adachi M, Kawasaki Y, Matsuda K, Shinohara K. Sarcoid- osis acutely involving the musculoskeletal system. Intern Med. 2007;46(17):1471-4.
Resnick D, Niwayama G. Sarcoidosis. In: Resnick D editor. Diagnosis of Bone and Joint Disorders. Philadelphia: W.B. Saunders Company; 2002. pp. 4771-90.
Mostard RL, Prompers L, Weijers RE, van Kroonenburgh MJ, Wijnen PA, Geusens PP, Drent M. F-18 FDG PET/CT fordetecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med. 2012;37(1):21-5.
James DG, Neville E, Siltzbach LE. A worldwide review of sarcoidosis. Ann NY Acad Sci. 1976 278:321-34.
Shorr AF, Murphy FT, Gilliland WR, Hnatiuk W. Osseous disease in patients with pulmonary sarcoidosis and musculoskeletalsymptoms. Respir Med.2000;94(3):228-32.
Talmi D, Smith S, Mulligan ME. Central skeletal sarcoidosismimicking metastatic disease. Skeletal Radiol. 2008;37(8):757-61.
Waanders F, van Hengel P, Krikke A, Wesseling J, Nieboer P. Sarcoidosis mimicking metastatic disease: a case report and review of the literature. Neth J Med.2006;64(9):342-5.
Rşa-Figueroa I, Gantes MA, Erausquin C, Mhaidli H, Montesdeoca A. Vertebral sarcoidosis: clinical and imaging findings. Semin Arthritis Rheum. 2002;31(5):346-52.
Yaghmai I.Radiographic, angiographic and radionuclide manifestations of osseous sarcoidosis. Radio Graphics. 3(3):375-96.
Kobayashi A, Shinozaki T, Shinjyo Y, Kato K, Oriuchi N, WatanabeH, Takagishi K. FDG PET in the clinical evaluation of sarcoidosis with bone lesions. Ann Nucl Med. 2000;14:311-3.
Hasni SA, Kunz D, Finzel K, Gruber BL. Osseous sarcoidosistreated with tumor necrosis factor-inhibitors. Spine. 2010;35:E904-7.
Clarencon F, Silbermann-Hoffman O, Lebreton C, Fernandez P, Kerrou K, Marchand-Adam S, Hourseau M, Schouman-Claeys E, Feydy A. Diffuse spine involvement in sarcoidosis with sternal lytic lesions: two case report. Spine. 2007;32:E594-7.